CA Patent

CA3004796C — Pyrazole acc inhibitors and uses thereof

Assigned to Gilead Apollo LLC · Expires 2023-11-14 · 3y expired

What this patent protects

The invention provides pyrazole compounds of formula I inhibiting Acetyl CoA Carboxylase (ACC), compositions and uses thereof for the treatment of obesity or as fungicides.

USPTO Abstract

The invention provides pyrazole compounds of formula I inhibiting Acetyl CoA Carboxylase (ACC), compositions and uses thereof for the treatment of obesity or as fungicides.

Drugs covered by this patent

Patent Metadata

Patent number
CA3004796C
Jurisdiction
CA
Classification
—
Expires
2023-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Apollo LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.